Michael C. Thigpen*

, Chesley L. Richards*, Ruth Lynfield†, Nancy L. Barrett‡, Lee H. Harrison§, Kathryn E. Arnold¶, Arthur Reingold#, Nancy M. Bennett**, Allen S. Craig††, Ken Gershman‡‡, Paul R. Cieslak§§, Paige Lewis*, Carolyn M. Greene*, Bernard Beall*, Chris A. Van Beneden*, and for the Active Bacterial Core surveillance/Emerging Infections Program Network
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Minnesota Department of Health, Minneapolis, Minnesota, USA; ‡Connecticut Department of Public Health, Hartford, Connecticut, USA; §Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; ¶Georgia Department of Human Resources, Atlanta, Georgia, USA; #University of California at Berkeley School of Public Health, Berkeley, California, USA; **University of Rochester School of Medicine and Dentistry, Rochester, New York, USA; ††Tennessee Department of Health, Nashville, Tennessee, USA; ‡‡Colorado Department of Public Health and Environment, Denver, Colorado, USA; §§Oregon State Public Health, Portland, Oregon, USA; 1Presented at the 42nd Annual Meeting of the Infectious Diseases Society of America, September 30–October 3, 2004, Boston, Massachusetts, USA.;
Main Article
Table 4
Most common emm types identified in persons >65 y with invasive group A streptococcal infection, by residence, ABCs areas, 1998–2003*
| emm type |
No. LTCF case-patients (%), N = 324 |
No. community-based case-patients (%), N = 1,090 |
| 1 |
55 (17.0) |
233 (21.4) |
| 3 |
44 (13.6) |
141 (12.9) |
| 28 |
39 (12.0) |
122 (11.2) |
| 12 |
21 (6.5) |
116 (10.6) |
| 89 |
27 (8.3) |
61 (5.6) |
| 77 |
9 (2.8) |
39 (3.6) |
| 6 |
12 (3.7) |
22 (2.0) |
| 18 |
6 (1.9) |
28 (2.6) |
| 11 |
10 (3.1) |
23 (2.1) |
| 4 |
11 (3.4) |
21 (1.9) |
Main Article
Top of Page